TARS fundamentals
Tarsus Pharmaceuticals, Inc. financial statements, including revenue, expenses, and profit
The total revenue of TARS for the last quarter is 66.41 M USD, and it's 38.01% higher compared to the previous quarter. The net income of Q4 24 is -23.11 M USD.
Q3 '19
Q1 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: USD
Q3 '19
Q1 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
TTM